NVAX – Novavax, Inc.
Float Short %
28.59
Margin Of Safety %
Put/Call OI Ratio
0.58
EPS Next Q Diff
-1.17
EPS Last/This Y
3.81
EPS This/Next Y
-2.49
Price
7.84
Target Price
12.86
Analyst Recom
2.86
Performance Q
7.54
Relative Volume
1.3
Beta
2.67
Ticker: NVAX
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-07-25 | NVAX | 7.47 | 0.69 | 0.16 | 313066 |
| 2025-07-28 | NVAX | 7.28 | 0.76 | 0.16 | 294038 |
| 2025-07-29 | NVAX | 7.01 | 0.75 | 0.31 | 297435 |
| 2025-07-30 | NVAX | 6.84 | 0.75 | 0.18 | 300303 |
| 2025-07-31 | NVAX | 6.64 | 0.74 | 0.07 | 303468 |
| 2025-08-01 | NVAX | 6.57 | 0.72 | 0.19 | 308207 |
| 2025-08-04 | NVAX | 6.76 | 0.74 | 0.26 | 297174 |
| 2025-08-05 | NVAX | 6.74 | 0.73 | 0.21 | 301754 |
| 2025-08-06 | NVAX | 7.58 | 0.71 | 0.22 | 312058 |
| 2025-08-07 | NVAX | 8.79 | 0.70 | 0.21 | 314953 |
| 2025-08-08 | NVAX | 8.39 | 0.68 | 0.32 | 328129 |
| 2025-08-11 | NVAX | 8.03 | 0.70 | 0.23 | 311752 |
| 2025-08-12 | NVAX | 8.48 | 0.68 | 0.14 | 319676 |
| 2025-08-13 | NVAX | 8.84 | 0.67 | 0.25 | 321244 |
| 2025-08-14 | NVAX | 9.43 | 0.67 | 0.23 | 328226 |
| 2025-08-15 | NVAX | 9.59 | 0.66 | 0.07 | 339530 |
| 2025-08-18 | NVAX | 9.7 | 0.69 | 0.07 | 309073 |
| 2025-08-19 | NVAX | 9.55 | 0.61 | 0.10 | 336134 |
| 2025-08-20 | NVAX | 8.73 | 0.61 | 0.27 | 338927 |
| 2025-08-21 | NVAX | 7.63 | 0.59 | 0.55 | 345995 |
| 2025-08-22 | NVAX | 7.84 | 0.58 | 0.46 | 360943 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-07-25 | NVAX | 7.47 | -111.2 | - | 2.41 |
| 2025-07-28 | NVAX | 7.30 | -111.2 | - | 2.41 |
| 2025-07-29 | NVAX | 7.01 | -111.2 | - | 2.41 |
| 2025-07-30 | NVAX | 6.85 | -111.2 | - | 2.41 |
| 2025-07-31 | NVAX | 6.65 | -111.2 | - | 2.41 |
| 2025-08-01 | NVAX | 6.56 | -111.2 | - | 2.41 |
| 2025-08-04 | NVAX | 6.75 | -111.2 | - | 2.41 |
| 2025-08-05 | NVAX | 6.73 | -111.2 | - | 2.41 |
| 2025-08-06 | NVAX | 7.59 | -94.3 | - | 2.46 |
| 2025-08-07 | NVAX | 8.78 | -94.3 | - | 2.46 |
| 2025-08-08 | NVAX | 8.37 | -35.0 | - | 2.53 |
| 2025-08-11 | NVAX | 8.04 | -35.0 | - | 2.53 |
| 2025-08-12 | NVAX | 8.48 | -13.6 | - | 2.58 |
| 2025-08-13 | NVAX | 8.85 | -13.6 | - | 2.58 |
| 2025-08-14 | NVAX | 9.43 | -13.6 | - | 2.58 |
| 2025-08-15 | NVAX | 9.58 | -13.6 | - | 2.58 |
| 2025-08-18 | NVAX | 9.70 | -13.6 | - | 2.58 |
| 2025-08-19 | NVAX | 9.52 | -13.6 | - | 2.58 |
| 2025-08-20 | NVAX | 8.73 | -13.6 | - | 2.58 |
| 2025-08-21 | NVAX | 7.63 | -13.6 | - | 2.58 |
| 2025-08-22 | NVAX | 7.84 | -13.6 | - | 2.58 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-07-25 | NVAX | 0.00 | -4.70 | 29.20 |
| 2025-07-28 | NVAX | 0.00 | -4.79 | 29.20 |
| 2025-07-29 | NVAX | 0.00 | -4.79 | 29.20 |
| 2025-07-30 | NVAX | 0.00 | -4.79 | 29.20 |
| 2025-07-31 | NVAX | 0.00 | -4.79 | 29.20 |
| 2025-08-01 | NVAX | 0.00 | -4.79 | 29.20 |
| 2025-08-04 | NVAX | 0.00 | -2.96 | 29.20 |
| 2025-08-05 | NVAX | 0.00 | -2.96 | 29.20 |
| 2025-08-06 | NVAX | 0.00 | -2.96 | 29.20 |
| 2025-08-07 | NVAX | 0.00 | -2.96 | 29.20 |
| 2025-08-08 | NVAX | 0.00 | -2.96 | 29.20 |
| 2025-08-11 | NVAX | 0.00 | -3.12 | 29.12 |
| 2025-08-12 | NVAX | 0.00 | -3.12 | 28.59 |
| 2025-08-13 | NVAX | 0.00 | -3.12 | 28.59 |
| 2025-08-14 | NVAX | 0.00 | -3.12 | 28.59 |
| 2025-08-15 | NVAX | 0.00 | -3.12 | 28.59 |
| 2025-08-18 | NVAX | 0.00 | -1.20 | 28.59 |
| 2025-08-19 | NVAX | 0.00 | -1.20 | 28.59 |
| 2025-08-20 | NVAX | 0.00 | -1.20 | 28.59 |
| 2025-08-21 | NVAX | 0.00 | -1.20 | 28.59 |
| 2025-08-22 | NVAX | 0.00 | -1.20 | 28.59 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.62
Avg. EPS Est. Current Quarter
-0.55
Avg. EPS Est. Next Quarter
-0.55
Insider Transactions
Institutional Transactions
-1.2
Beta
2.67
Average Sales Estimate Current Quarter
51
Average Sales Estimate Next Quarter
141
Fair Value
Quality Score
98
Growth Score
32
Sentiment Score
22
Actual DrawDown %
97.6
Max Drawdown 5-Year %
-98.8
Target Price
12.86
P/E
3.47
Forward P/E
PEG
0.09
P/S
1.18
P/B
33.79
P/Free Cash Flow
EPS
2.26
Average EPS Est. Cur. Y
2.58
EPS Next Y. (Est.)
0.09
Target Price Estimates Raised
Target Price Estimates Lowered
1
Profit Margin
39.2
Relative Volume
1.3
Return on Equity vs Sector %
Return on Equity vs Industry %
EPS 1 7Days Diff
0.2
EPS 1 30Days Diff
0.03
EBIT Estimation
Novavax, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 952
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
stock quote shares NVAX – Novavax, Inc. Stock Price stock today
news today NVAX – Novavax, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch NVAX – Novavax, Inc. yahoo finance google finance
stock history NVAX – Novavax, Inc. invest stock market
stock prices NVAX premarket after hours
ticker NVAX fair value insiders trading